Heart Attack Diagnostics Market to grow at a CAGR of 7.1% during 2024-2028
The Heart Attack Diagnostics Market is expected to grow at a CAGR of 7.1% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 4990.6 million. In the Heart Attack Diagnostics Market, vendors are strategically investing in new product development and research and development activities to maintain their competitive edge. Innovative heart attack diagnostic devices, such as advanced electrocardiogram (ECG) machines and Troponin tests, are being introduced to improve clinical outcomes. Notable market players, including Boston Scientific and Edwards Lifesciences Corp., are also focusing on the development of technologically advanced 3D mammography equipment for future launches. This strategic approach enables vendors to sustain their market position and drive growth in the fragmented heart attack diagnostics industry.
Get more information on Heart Attack Diagnostics Market by requesting a sample report
Technavio analysts predict that the Hospitals subsegment will lead the End-user segment during 2024 and 2028 The global heart attack diagnostics market is primarily driven by the significant revenue generation from the hospitals segment. Factors such as the increasing prevalence of risk factors for cardiovascular diseases (CVDs), including hypertension, high blood cholesterol, and smoking, have led to a surge in the number of heart attack cases worldwide. This trend has resulted in an increased demand for the detection of biomarkers such as troponin, C-Reactive Protein, and creatine kinase. The establishment of new cardiology hospitals and expansion of existing ones is a direct response to this need. Furthermore, changes in reimbursement regulations by the Centers for Medicare and Medicaid Services (CMS) have accelerated this growth.
Here are the various ways based on which the market is segmented:
There are several factors that are causing the market to flourish rising prevalence of cardiac disorders
Learn which are the obstacles that the market is experiencing in the way of its growth by accessing the free PDF report
The Heart Attack Diagnostics Market has witnessed significant growth in recent years due to the increasing prevalence of cardiovascular diseases (CVDs) and non-communicable diseases (NCDs) caused by unhealthy lifestyles, sedentary lifestyles, hypertension, high blood pressure, and other metabolic factors. Medical technology has played a crucial role in the diagnosis of heart attacks, with diagnostic modalities such as Cardiac MRI, Coronary angiography, Echocardiography, Imaging tests, and ECG technology being commonly used. Clinical trials are ongoing to develop more accurate and less invasive diagnostic tests for heart attacks. Symptoms of a heart attack include breathing difficulty, exhaustion, and chest pain. Troponin, a protein released into the bloodstream during a heart attack, is often used to diagnose myocardial infarction. Environmental and behavioral factors, such as sedentary lifestyles and unhealthy lifestyle choices, also contribute to the risk of heart attacks. Cardiac diagnostic tests are essential for early detection and treatment of heart attacks, which can help prevent long-term damage and improve patient outcomes. The diagnostic tests help assess blood flow obstruction and oxygen supply to the heart muscle, enabling healthcare professionals to develop effective treatment plans. Overall, the Heart Attack Diagnostics Market is expected to continue growing due to the increasing burden of CVDs and NCDs and the ongoing development of advanced diagnostic technologies.
The global life sciences tools and services market encompasses businesses involved in the research and development (R&D) of a diverse range of product categories, including capital equipment, instruments, accessories, and consumables. These tools are utilized in the pharmaceutical and biotechnology industries for product development and laboratory diagnosis of various diseases. Additionally, this market includes life sciences-related services such as contract research, manufacturing, and sales. According to Technavio, the healthcare industry's total market size is determined by the consolidated revenue generated by manufacturers of equipment, supplies, pharmaceuticals, biotechnology, and life science tools and services. The expansion of the global life science tools and services market will be fueled by several factors, including the increasing aging population, with the proportion of the global population over 60 years projected to rise significantly.
The Heart Attack Diagnostics Market is experiencing significant growth, fueled by the rising prevalence of cardiac disorders. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
